| |
| |
|
| Insider
Information: |
Paulson Thomas J |
| Relationship: |
CFO |
| City: |
Alameda |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
142,196 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,158 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,196 |
|
|
| Total
Value |
$12,158 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novabay Pharmaceuticals Inc |
NBY |
CFO |
2015-10-05 |
142,196 |
2008-03-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• • – |
2015-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
142,196 |
0 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• • – |
2015-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
23,986 |
92,196 |
0 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• • – |
2014-12-12 |
4 |
B |
$0.68 |
$6,800 |
D/D |
10,000 |
68,210 |
2.74 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• • – |
2014-12-09 |
4 |
B |
$0.67 |
$6,700 |
D/D |
10,000 |
58,210 |
2.74 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• • – |
2013-10-28 |
4 |
D |
$1.75 |
$6,379 |
D/D |
(3,645) |
63,855 |
0 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• • – |
2012-12-06 |
4 |
B |
$1.24 |
$12,400 |
D/D |
10,000 |
63,855 |
2.74 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• • – |
2012-10-27 |
4 |
D |
$1.31 |
$4,775 |
D/D |
(3,645) |
53,855 |
0 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• – – |
2012-05-30 |
4 |
B |
$0.94 |
$9,364 |
D/D |
10,000 |
17,500 |
2.74 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• – – |
2011-10-27 |
4 |
A |
$1.09 |
$43,600 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• – – |
2011-08-26 |
4 |
B |
$0.86 |
$3,010 |
D/D |
3,500 |
7,500 |
2.66 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• – – |
2008-09-12 |
4 |
B |
$1.92 |
$3,669 |
D/D |
1,900 |
4,000 |
2.66 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
CFO |
• – – |
2008-09-11 |
4 |
B |
$1.70 |
$170 |
D/D |
100 |
2,100 |
2.66 |
- |
|
| NBY |
Novabay Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2008-03-14 |
4 |
B |
$2.70 |
$5,400 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
